Baseline [18F]FDG PET features are associated with survival and toxicity in patients treated with CAR T cells for large B cell lymphoma
E. Marchal, Xavier Palard-Novello, Faustine Lhomme, M.‐E. Meyer, Guillaume Manson, Anne Devillers, Jean‐Pierre Marolleau, Roch Houot, Antoine Girard
Topics & Concepts
MedicineCytokine release syndromeLymphomaAdverse effectInternal medicineGastroenterologyOncologyChimeric antigen receptorCancerImmunotherapyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers